In summary, qSOFA should not be used as a single screening tool for sepsis. NEWS, MEWS, or SIRS may be more beneficial at this time.
Explore This Issue
ACEP Now: Vol 43 – No 06 – June 20242. Lactate clearance and capillary refill time (CRT)
Most institutions are beginning to transition to electronic health record-generated order sets for sepsis when it is suspected by the practitioner; however, the “necessary” labs to obtain have varied by clinical center. Specifically, lactate clearance has been a debatable topic since its inception. The SSC guidelines for 2021 weakly recommended measuring blood lactate and, if elevated (defined as ≥4 mmol/L), guiding resuscitation by a decrease in its value over time.7 The ANDROMEDA-SHOCK study evaluated whether targeting resuscitation towards a CRT versus lactate clearance led to a reduced mortality at 28 days; ultimately, there was no detectable difference. The CRT group’s mortality rate was 34.9 percent versus 43.4 percent in the lactate group.9 A concern raised with both strategies was whether volume overload and its early recognition was key to preventing further complications as a result of over-resuscitation. ACEP’s own clinical policy does not recommend the use of serum lactate levels to guide ongoing IV fluid resuscitation, as it has not been found to be an accurate marker of ongoing fluid needs.10
In summary, there is no good “endpoint” guiding resuscitation in septic shock, but CRT or lactate clearance can be considered.
3. Intravenous fluids
One of the greatest controversies in the care of sepsis has been intravenous fluid management during the acute stages of septic shock. For patients in septic shock or exhibiting signs of hypoperfusion, SSC guidelines weakly recommend at least 30 mL/kg of intravenous crystalloid within the first three hours of resuscitation.7 The current fluid recommendation is a balanced crystalloid, with lactated ringers being superior to normal saline.5 The CLOVERS trial investigated conventional fluid resuscitation versus early vasopressor use and intravenous fluid restriction, with the conventional group receiving approximately 3.8 L and the fluid restriction group receiving 1.8 L. Researchers concluded that at 90 days, mortality and adverse events of the aforementioned volumes were similar between the two groups.11 Notably, ACEP’s clinical policy does not endorse an empirical fluid bolus but, rather, individualized fluid resuscitation needs for each patient.10 The judicious amount of intravenous fluids cited by the SSC should also be liberalized for patients with clinical findings of volume overload or a known reduced ejection fraction.
In summary, the current recommendation is 30 mL/kg of lactated ringers within the first three hours of resuscitation, with the caveat of utilizing clinical judgment to prevent fluid overload.
One Response to “Updates in the Management of Severe Sepsis and Septic Shock”
July 1, 2024
Joseph R Shiber, MDDear ACEPNow Editor,
Excellent synopsis of ED treatment of septic shock but I would like to add a few clarifications. The preferred balanced IVF is Plasmalyte-A since LR is somewhat hypotonic (Na 130) and uses lactate as a buffer, compared to acetate and gluconate in Plasmalyte-A (Na 140). The additional lactate is not actually detrimental to cellular activity but can hamper the usefulness of tracking lactate levels especially with hepatic or mitochondrial dysfunction where lactate is not being converted back to pyruvate for preparation to enter the TCA cycle. The optimal vasopressor for septic shock should correct the hemodynamic disorder(s) causing the tissue hypoxia. Levophed is certainly the most useful to help restore vascular tone (alpha effect) in the low SVR vasodilatory state of distributive shock while supplying a small B1-2 effect but there are cases where an inappropriate heart-rate response occurs (HR <80) due to medications (such as AVN blockers) or to intrinsic chronotropic failure (age or sepsis related). In these cases, it is paramount to address the heart rate at the same time, since if the heart rate remains inappropriately low while simply increasing SVR the cardiac output and tissue perfusion will potentially go down not up. Lastly, although ECMO is well recognized as a rescue for ARDS (V-V) and circulatory shock (V-A) it should be noted that active bacteremia or fungemia is a contraindication since the circuit will be contaminated immediately and cannot be sterilized.
Respectfully,
Joseph Shiber, MD, FACEP, FACP, FNCS, FCCM